{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "26376419",
  "DateCompleted": {
    "Year": "2017",
    "Month": "11",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "11",
    "Day": "28"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "dan"
    ],
    "ELocationID": [
      "V02150184"
    ],
    "Journal": {
      "ISSN": "1603-6824",
      "JournalIssue": {
        "Volume": "177",
        "Issue": "38",
        "PubDate": {
          "Year": "2015",
          "Month": "Sep",
          "Day": "14"
        }
      },
      "Title": "Ugeskrift for laeger",
      "ISOAbbreviation": "Ugeskr Laeger"
    },
    "ArticleTitle": "[Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].",
    "Pagination": {
      "StartPage": "V02150184",
      "MedlinePgn": "V02150184"
    },
    "Abstract": {
      "AbstractText": [
        "Chronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important common risk factor and there is a high prevalence of cardiovascular disease among COPD patients. Although cardioselective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "daniel.rasmussen@live.dk."
          }
        ],
        "LastName": "Rasmussen",
        "ForeName": "Daniel Bech",
        "Initials": "DB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lange",
        "ForeName": "Peter",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Jensen",
        "ForeName": "Magnus Thorsten",
        "Initials": "MT"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Betablokkere kan gavne patienter med KOL og hjertesygdom."
  },
  "MedlineJournalInfo": {
    "Country": "Denmark",
    "MedlineTA": "Ugeskr Laeger",
    "NlmUniqueID": "0141730",
    "ISSNLinking": "0041-5782"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenergic beta-Antagonists"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenergic beta-Antagonists"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "mortality",
        "physiopathology"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "mortality",
        "physiopathology"
      ],
      "DescriptorName": "Pulmonary Disease, Chronic Obstructive"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}